Cristina Larkin
2017
In 2017, Cristina Larkin earned a total compensation of $1.2M as Chief Operating Officer at Spero Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $98,325 |
|---|---|
| Option Awards | $796,800 |
| Salary | $330,669 |
| Other | $734 |
| Total | $1,226,528 |
Larkin received $796.8K in option awards, accounting for 65% of the total pay in 2017.
Larkin also received $98.3K in non-equity incentive plan, $330.7K in salary and $734 in other compensation.
Rankings
In 2017, Cristina Larkin's compensation ranked 7,997th out of 14,666 executives tracked by ExecPay. In other words, Larkin earned more than 45.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,997 out of 14,666 | 46th |
Division Manufacturing | 3,004 out of 5,772 | 48th |
Major group Chemicals And Allied Products | 984 out of 2,075 | 53rd |
Industry group Drugs | 769 out of 1,731 | 56th |
Industry Pharmaceutical Preparations | 606 out of 1,333 | 55th |
Source: SEC filing on April 26, 2019.
Larkin's colleagues
We found three more compensation records of executives who worked with Cristina Larkin at Spero Therapeutics in 2017.